Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beth P Goldstein

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
The Journal of Antibiotics|August 14, 2014
Resistance to rifampicin: a reviewBeth P Goldstein
The Journal of Antimicrobial Chemotherapy|March 8, 2005
Origin, structure, and activity in vitro and in vivo of dalbavancinAdriano Malabarba, Beth P Goldstein
Journal of Bacteriology|April 5, 2005
Cross-resistance of Escherichia coli RNA polymerases conferring rifampin resistance to different antibioticsMing Xu, Yan Ning Zhou, Beth P Goldstein, et al.
Diagnostic Microbiology and Infectious Disease|February 7, 2006
Microbiologic characterization of isolates from a dalbavancin clinical trial for catheter-related bloodstream infectionsBeth P Goldstein, Ronald N Jones, Thomas R Fritsche, et al.
International Journal of Antimicrobial Agents|January 18, 2006
In vitro interactions of anidulafungin with azole antifungals, amphotericin B and 5-fluorocytosine against Candida speciesJames A Karlowsky, Daryl J Hoban, George G Zhanel, et al.
Journal of Clinical Pharmacology|July 18, 2008
Pharmacokinetic-pharmacodynamic modeling of dalbavancin, a novel glycopeptide antibioticJames A Dowell, Beth P Goldstein, Mary Buckwalter, et al.
Journal of Clinical Microbiology|August 8, 2006
Comparison of dalbavancin MIC values determined by Etest (AB BIODISK) and reference dilution methods using gram-positive organismsThomas R Fritsche, Robert P Rennie, Beth P Goldstein, et al.
Antimicrobial Agents and Chemotherapy|January 6, 2010
Activity of dalbavancin against Bacillus anthracis in vitro and in a mouse inhalation anthrax modelHenry S Heine, Bret K Purcell, Jennifer Bassett, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2003
Disk diffusion-based methods for determining Candida parapsilosis susceptibility to anidulafunginZekaver Odabasi, Victor Paetznick, Beth P Goldstein, et al.
The Journal of Antimicrobial Chemotherapy|March 8, 2005
In vitro antistaphylococcal activity of dalbavancin, a novel glycopeptideSara Lopez, Corinne Hackbarth, Gabriella Romanò, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
The Journal of Antibiotics|August 14, 2014
Resistance to rifampicin: a reviewBeth P Goldstein
The Journal of Antimicrobial Chemotherapy|March 8, 2005
Origin, structure, and activity in vitro and in vivo of dalbavancinAdriano Malabarba, Beth P Goldstein
Journal of Bacteriology|April 5, 2005
Cross-resistance of Escherichia coli RNA polymerases conferring rifampin resistance to different antibioticsMing Xu, Yan Ning Zhou, Beth P Goldstein, et al.
Diagnostic Microbiology and Infectious Disease|February 7, 2006
Microbiologic characterization of isolates from a dalbavancin clinical trial for catheter-related bloodstream infectionsBeth P Goldstein, Ronald N Jones, Thomas R Fritsche, et al.
International Journal of Antimicrobial Agents|January 18, 2006
In vitro interactions of anidulafungin with azole antifungals, amphotericin B and 5-fluorocytosine against Candida speciesJames A Karlowsky, Daryl J Hoban, George G Zhanel, et al.
Journal of Clinical Pharmacology|July 18, 2008
Pharmacokinetic-pharmacodynamic modeling of dalbavancin, a novel glycopeptide antibioticJames A Dowell, Beth P Goldstein, Mary Buckwalter, et al.
Journal of Clinical Microbiology|August 8, 2006
Comparison of dalbavancin MIC values determined by Etest (AB BIODISK) and reference dilution methods using gram-positive organismsThomas R Fritsche, Robert P Rennie, Beth P Goldstein, et al.
Antimicrobial Agents and Chemotherapy|January 6, 2010
Activity of dalbavancin against Bacillus anthracis in vitro and in a mouse inhalation anthrax modelHenry S Heine, Bret K Purcell, Jennifer Bassett, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2003
Disk diffusion-based methods for determining Candida parapsilosis susceptibility to anidulafunginZekaver Odabasi, Victor Paetznick, Beth P Goldstein, et al.
The Journal of Antimicrobial Chemotherapy|March 8, 2005
In vitro antistaphylococcal activity of dalbavancin, a novel glycopeptideSara Lopez, Corinne Hackbarth, Gabriella Romanò, et al.
Pageof 2